Batavia Biosciences and Valneva Sweden AB, the Swedish subsidiary of Valneva SE announced that they have entered into a collaboration agreement to…
Valneva announced that the antitrust-related condition precedent for its Lyme vaccine collaboration agreement with Pfizer has been met. As a result,…
Researchers at IMBA and IMP develop a new CRISPR tool that predicts effective guide RNAs with unprecedented precision. They named it Vienna…
CEBINA announced that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale…
Eveliqure Biotechnologies has announced that the Hungarian regulatory agency OGYÈI has approved the clinical trial for its vaccine program to prevent…
Valneva announced the publication of full data from the Phase 1 clinical trial of its chikungunya vaccine candidate, VLA1553, in the peer-reviewed…
Researchers from the lab of Florian Raible at the Max Perutz Labs and their collaborators have developed an improved tissue clearing and…
Birthdays should be celebrated, even in challenging times. Last year marked the inaugural celebration of the birthday of Max Perutz, the man who gave…
The Vienna Drosophila Resource Center was a guest in the Austria-wide radio station Ö1.
Jürgen Knoblich, Scientific Director of IMBA – Institute of Molecular Biotechnology by the Austrian Academy of Sciences – is now part of the Board of…
Scientists from Sascha Martens Lab at the Max Perutz Labs and their colleagues from the University of Berkeley (USA) have reconstituted the activity…
An international team of researchers with the participation of IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences –…
